The largest, most respected 3D medical image post-processing lab in the nation LOUISVILLE, KY, UNITED STATES, November 4, 2024 /EINPresswir ...

Increased contract wins from the Pentagon and other US allies have been a primary growth driver for the company.

Focus Financial Network Inc. lowered its stake in Leidos Holdings, Inc. (NYSE:LDOS – Free Report) by 10.3% during the third quarter, according to the company in its most recent disclosure with the ...

Barclays raised the firm’s price target on Leidos (LDOS) to $210 from $165 and keeps an Overweight rating on the shares following the earnings report. Published first on TheFly – the ultimate source ...

Barclays analyst David E. Strauss maintained a Buy rating on Leidos Holdings (LDOS – Research Report) on November 1 and set a price ...

Leidos (LDOS) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its ...

Leidos (NYSE:LDOS – Get Free Report) had its price objective lifted by investment analysts at Wells Fargo & Company from $183.00 to $230.00 in a research note issued on Wednesday, Benzinga reports.

Leidos (NYSE:LDOS) announced today a new contract to provide critical supply support for weapons systems that keep the U.S.

Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate ...

On the heels of its strong third-quarter sales and bookings, Leidos raised its full-year sales target to between $16.35 billion and $16.45 billion. Previously, management had guided for sales to come ...

Leidos Holdings, Inc reported Q3 revenue growth of 7%, beating analyst estimates and driven by demand for managed health services. Adjusted EPS up 44%.